Extended Use of MAO-B Inhibitors Slows Decline in Parkinson’s Disease Patients

There has long been interest in whether monoamine oxidase type B (MAO-B) inhibitors slow progression of Parkinson’s disease (PD) and improve long-term outcomes. They have shown neuroprotective effects in cell culture and animal studies of ... Read more

Read the whole article on Science Blog

More from Science Blog